Skip Navigation

Invest in Bioventus Inc on Stash

Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone. The minimally invasive fracture treatment offers its Exogen system for the non-invasive treatment of established nonunion fractures and certain fresh fractures.

To buy fractional shares of Bioventus Inc stock, you'll need to sign up for Stash and open a personal portfolio.
Bioventus Inc

Ticker: BVS

Bioventus Inc

$8.98

+2.63%

(1W)
Feb ’26Mar ’26$9$9$10

$

BVS Performance Breakdown

Share Price

 

$8.98

Today's change

 

-1.32%

Year to date change (YTD)

 

24.55%

Dividend yield

 

0.0

Last dividend paid

 

N/A

Last dividend pay date

 

N/A

About BVS

Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone. The minimally invasive fracture treatment offers its Exogen system for the non-invasive treatment of established nonunion fractures and certain fresh fractures.

Bioventus Inc Stock Ticker

BVS

For more information

https://www.bioventus.com/

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Bioventus Inc stock news

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,8 recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.1

Learn how to invest

Get professional advice and education at every step.

How to buy Bioventus Inc stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Stash offers two subscription plans: Stash Growth and Stash+.

Once your market order of Bioventus Inc stock is complete, you'll officially be a shareholder of Bioventus Inc!

Invest in Bioventus Inc on Stash

Bioventus Inc is a global medical device company. The Company is focused on developing and commercializing clinically and minimally invasive treatments that engage and enhance the body’s natural healing process. The Company’s portfolio of products includes OA joint pain treatment and joint preservation, bone graft substitutes and minimally invasive fracture treatment. The OA joint pain treatment and joint preservation is focused on orthopedics. Its bone graft substitutes (BGSs) offers portfolio of products including human tissue allografts and synthetics. Its BGS products can be used in conjunction with any orthopedic fixation and spinal fusion implant. They are designed to improve bone fusion rates following spinal fusion and other orthopedic surgeries and reduce the need for using the patient’s own bone. The minimally invasive fracture treatment offers its Exogen system for the non-invasive treatment of established nonunion fractures and certain fresh fractures.

To buy fractional shares of Bioventus Inc stock, you'll need to sign up for Stash and open a personal portfolio.